David Nathaniel E 4
4 · Unity Biotechnology, Inc. · Filed Jun 26, 2023
Insider Transaction Report
Form 4
David Nathaniel E
DirectorPresident
Transactions
- Award
Stock Option (Right to Buy)
2023-06-23+6,000→ 6,000 totalExercise: $3.25Exp: 2033-06-22→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 23, 2023 or (ii) the date of the 2024 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.